| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8785798 | Cancer Treatment Reviews | 2018 | 30 Pages |
Abstract
The aim of this paper is to focus on the biological rationale of adding radiation therapy to immune-modulating agents in renal cell carcinoma and to review the currently available clinical evidence about the combination of radiotherapy and immunotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Consuelo Buttigliero, Simona Allis, Marcello Tucci, Clizia Zichi, Gianmarco Leone, Rosario Francesco Di Stefano, Maria Grazia Ruo Redda, Umberto Ricardi, Giorgio Vittorio Scagliotti, Massimo Di Maio, Andrea Riccardo Filippi,